MADRID (Reuters) - Shares of Spain´s PharmaMar PHMR.MC jumped on Friday after the company said its coronavirus diagnosis kits have been certified to be marketed within the European Union.
The company said on Friday its product received certification after being tested on samples from actual patients with the coronavirus.
Shares were up 16% to 4.62 euros on Friday afternoon, while the Madrid main stock index was down 3.5%.
Reporting by Inti Landauro, Editing by Nathan Allen
Our Standards: The Thomson Reuters Trust Principles.